Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02652533 · ClinicalTrials.gov registry record

Ultrasound Shear Wave Elastography Evaluation of Suspected and Known Biliary Atresia

A clinical trial of Biliary Atresia, sponsored by Children's Hospital Medical Center, Cincinnati.

Completed
Registry status
41
Enrollment target
4
Study locations

NCT02652533 is a study of Biliary Atresia that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 41 participants, below the 569-participant average among 7 other Biliary Atresia trials with a reported enrollment target (93% lower). The trial reports 4 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02652533, a study of Biliary Atresia, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.

COMPLETED
Registry status
41 participants
Enrollment target
4
Study locations

Study Summary

The investigators plan to investigate the use of US shear wave elastography (SWE), a newly available imaging technology, in children with suspected/known BA.

Conditions Studied

Interventions

  • DEVICE Ultrasound Shear Wave Elastography

Study Locations (4)

Ohio

  • Cincinnati Children's Hospital Medical Center - Cincinnati
  • Nationwide Children's - Columbus

California

  • Lucile Packard Children's Hospital/Stanford University - Stanford

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 41 participants
Start Date 2016-09
Est. Completion 2019-07

What the Registry Record Tells You About NCT02652533

The ClinicalTrials.gov registry entry for NCT02652533 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 569-participant average among 7 other Biliary Atresia trials with a reported enrollment target (93% lower). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Biliary Atresia appearing as the primary indexed condition, and to 1 intervention - of which Ultrasound Shear Wave Elastography is the first listed.

NCT02652533 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Ohio, California, Michigan.

Frequently Asked Questions

What is clinical trial NCT02652533 about?

NCT02652533 is a clinical study titled "Ultrasound Shear Wave Elastography Evaluation of Suspected and Known Biliary Atresia". The investigators plan to investigate the use of US shear wave elastography (SWE), a newly available imaging technology, in children with suspected/known BA.

What is the current status of trial NCT02652533?

This trial is currently completed. The enrollment target is 41 participants. The study started on 2016-09. Estimated completion is 2019-07.

What conditions does trial NCT02652533 study?

This clinical trial studies the following conditions: Biliary Atresia.

What interventions are being tested in trial NCT02652533?

The interventions under investigation include: Ultrasound Shear Wave Elastography (DEVICE).

Who is sponsoring clinical trial NCT02652533?

This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02652533 being conducted?

This trial has 4 study locations across California, Michigan, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Biliary Atresia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.